In this episode we discuss:
Join the Bio Breakthroughs podcast host, Jared S Taylor, as he welcomes Ravi Samavedam, Chief Innovation Officer at Azzur Group. In this insightful conversation, Ravi discusses Azzur Group’s innovative approaches to addressing lab space challenges in the biotech and pharma industries.
What you’ll get out of this episode:
- Ravi Samavedam, Chief Innovation Officer at Azzur Group, shares insights on lab space solutions for biotech and pharma industries.
- How they offer clean rooms on demand, enabling rapid GMP manufacturing setups, alleviating lab space shortage in key biotech hubs.
- Flexibility is a key advantage – clients can customize clean room configurations and benefit from comprehensive support services.
- Taking GMP burden off clients by providing operationalized facilities, quality management, and support staff.
- Aiming to accelerate therapies, Azzur Group focuses on cell and gene therapy innovation, expanding its footprint across the US and beyond.
Watch
Listen
Read
Overview of Ravi Samavedam’s Background
Ravi Samavedam introduces himself as a seasoned biochemical engineer with over 23 years of industry experience. He emphasizes his background in biotech product manufacturing, quality validation, and consulting, sharing his valuable insights gained from his journey.
Who is Azzur Group?
Ravi outlines Azzur Group’s role as a leading service provider catering to the biotech, pharma, and device sectors. With 13 offices nationwide, Azzur Group offers consulting, clean room facilities, lab services, and training to support GMP manufacturing and quality needs.
Clean Rooms on Demand: Addressing Lab Space Shortage
Ravi delves into Azzur Group’s innovative solution for lab space shortage – Clean Rooms on Demand. These modular, panel-based clean room facilities are strategically located in biotech hubs across the US. Offering flexible configurations and wraparound services, these clean rooms accelerate manufacturing setup and alleviate GMP compliance challenges.
Advantages of Clean Rooms on Demand
Ravi explains that Clean Rooms on Demand offer speed and flexibility. Companies can occupy existing infrastructure, reducing the time required for GMP manufacturing setup. Azzur Group’s staff manage the facility and support services, enabling clients to focus on scientific research and manufacturing.
Distinguishing from CDMOs
Ravi highlights the differences between Azzur Group’s model and Contract Development and Manufacturing Organizations (CDMOs). Azzur Group’s approach suits companies aiming to internalize manufacturing while conserving capital. The flexible model empowers clients to make multiple batches without rigid scheduling constraints.
Future Outlook and Expansion
Ravi discusses Azzur Group’s expansion plans, targeting secondary biotech hubs and advanced therapy modalities. The company envisions growth within the US and potentially beyond. Ravi’s excitement lies in the opportunity to accelerate therapies from preclinical to commercial stages, positively impacting patients’ access to innovative treatments.
Wrap Up!
Ravi Samavedam’s interview sheds light on Azzur Group’s groundbreaking solutions for lab space challenges. Their Clean Rooms on Demand concept presents an innovative and flexible approach to GMP manufacturing, supporting biotech and pharma companies in bringing life-changing therapies to market faster.
WORD FROM OUR SPONSORS:
Our sponsor for this episode are Sage Growth Partners.
Sage Growth Partners accelerates commercial success for healthcare organizations through a singular focus on growth. The company helps its clients thrive amid the complexities of a rapidly changing marketplace with deep domain expertise and an integrated application of research, strategy, and marketing. For more information, please go to www.sage-growth.com & follow Sage Growth Partners on social media – @sagegrowthpartners
Learn more about Azzur Group follow these links:
Also, be sure to follow Slice of Healthcare on our social channels:
– Website – LinkedIn – Twitter – YouTube – Newsletter –
